[ Price : $8.95]
Researchers in China say they found several new adverse event signals in their review of 20 years of FDA adverse event reports on ...[ Price : $8.95]
A Friends of Cancer Research study update says FDA continues to review and approve novel cancer drugs faster than the European Med...[ Price : $8.95]
Sanofi and Johnson & Johnson stop the development of their vaccine candidate for extraintestinal pathogenic E. coli because Phase ...[ Price : $8.95]
The DC District Court rules for FDA in a Vanda Pharmaceuticals lawsuit seeking an agency order to revoke the approval of a Teva AN...[ Price : $8.95]
The Department of Justice has requested information from Inspire Medical as part of a civil probe into its marketing, promotion, a...[ Price : $8.95]
FDA clarifies its enforcement discretion timeframes for compounded tirzepatide.[ Price : $8.95]
FDA approves a Genentech NDA for a new tablet formulation of Evrysdi (risdiplam) for treating people with spinal muscular atrophy.[ Price : $8.95]
Travere Therapeutics says it will submit an sNDA to FDA for a new indication for its Filspari to treat focal segmental glomerulosc...